TY - JOUR
T1 - Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function
AU - Papa, Antonella
AU - Wan, Lixin
AU - Bonora, Massimo
AU - Salmena, Leonardo
AU - Song, Min Sup
AU - Hobbs, Robin M.
AU - Lunardi, Andrea
AU - Webster, Kaitlyn
AU - Ng, Christopher
AU - Newton, Ryan H.
AU - Knoblauch, Nicholas
AU - Guarnerio, Jlenia
AU - Ito, Keisuke
AU - Turka, Laurence A.
AU - Beck, Andy H.
AU - Pinton, Paolo
AU - Bronson, Roderick T.
AU - Wei, Wenyi
AU - Pandolfi, Pier Paolo
N1 - Funding Information:
The authors would like to thank Pandolfi lab members for critical comments and Thomas Garvey for editing the manuscript. The authors are indebted to SuJung Song and Dimitrios Anastosiou for insightful discussion. A.P. was supported in part by the American-Italian Cancer Foundation Post-Doctoral Fellowship. M.B. and P.P. are supported by the Italian Association for Cancer Research (AIRC, grant number 14442). This work was supported by NIH grant U01-CA 141496 to P.P.P. L.A.T. has a family member employed by, and owns equity in, Novartis.
PY - 2014/4/24
Y1 - 2014/4/24
N2 - PTEN dysfunction plays a crucial role in the pathogenesis of hereditary and sporadic cancers. Here, we show that PTEN homodimerizes and, in this active conformation, exerts lipid phosphatase activity on PtdIns(3,4,5)P3. We demonstrate that catalytically inactive cancer-associated PTEN mutants heterodimerize with wild-type PTEN and constrain its phosphatase activity in a dominant-negative manner. To study the consequences of homo- and heterodimerization of wild-type and mutant PTEN in vivo, we generated Pten knockin mice harboring two cancer-associated PTEN mutations (PtenC124S and PtenG129E). Heterozygous PtenC124S/+ and PtenG129E/+ cells and tissues exhibit increased sensitivity to PI3-K/Akt activation compared to wild-type and Pten+/- counterparts, whereas this difference is no longer apparent between PtenC124S/- and Pten-/- cells. Notably, Pten KI mice are more tumor prone and display features reminiscent of complete Pten loss. Our findings reveal that PTEN loss and PTEN mutations are not synonymous and define a working model for the function and regulation of PTEN.
AB - PTEN dysfunction plays a crucial role in the pathogenesis of hereditary and sporadic cancers. Here, we show that PTEN homodimerizes and, in this active conformation, exerts lipid phosphatase activity on PtdIns(3,4,5)P3. We demonstrate that catalytically inactive cancer-associated PTEN mutants heterodimerize with wild-type PTEN and constrain its phosphatase activity in a dominant-negative manner. To study the consequences of homo- and heterodimerization of wild-type and mutant PTEN in vivo, we generated Pten knockin mice harboring two cancer-associated PTEN mutations (PtenC124S and PtenG129E). Heterozygous PtenC124S/+ and PtenG129E/+ cells and tissues exhibit increased sensitivity to PI3-K/Akt activation compared to wild-type and Pten+/- counterparts, whereas this difference is no longer apparent between PtenC124S/- and Pten-/- cells. Notably, Pten KI mice are more tumor prone and display features reminiscent of complete Pten loss. Our findings reveal that PTEN loss and PTEN mutations are not synonymous and define a working model for the function and regulation of PTEN.
UR - http://www.scopus.com/inward/record.url?scp=84897406995&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84897406995&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2014.03.027
DO - 10.1016/j.cell.2014.03.027
M3 - Article
C2 - 24766807
AN - SCOPUS:84897406995
SN - 0092-8674
VL - 157
SP - 595
EP - 610
JO - Cell
JF - Cell
IS - 3
ER -
